136 related articles for article (PubMed ID: 33761287)
1. Licarin A as a Novel Drug for Inflammatory Eye Diseases.
Paiva MRB; Vasconcelos-Santos DV; Coelho MM; Machado RR; Lopes NP; Silva-Cunha A; Fialho SL
J Ocul Pharmacol Ther; 2021 Jun; 37(5):290-300. PubMed ID: 33761287
[No Abstract] [Full Text] [Related]
2. Intravitreal lupeol: A new potential therapeutic strategy for noninfectious uveitis.
Toledo CR; Paiva MRB; Castro BFM; Pereira VV; Cenachi SPF; Vasconcelos-Santos DV; Fialho SL; Silva-Cunha A
Biomed Pharmacother; 2021 Nov; 143():112145. PubMed ID: 34507119
[TBL] [Abstract][Full Text] [Related]
3. Corosolic acid: antiangiogenic activity and safety of intravitreal injection in rats eyes.
Toledo CR; Pereira VV; Dourado LFN; Paiva MRB; Silva-Cunha A
Doc Ophthalmol; 2019 Jun; 138(3):181-194. PubMed ID: 30809742
[TBL] [Abstract][Full Text] [Related]
4. Glycosylation-enhanced biocompatibility of the supramolecular hydrogel of an anti-inflammatory drug for topical suppression of inflammation.
Xiong T; Li X; Zhou Y; Song Q; Zhang R; Lei L; Li X
Acta Biomater; 2018 Jun; 73():275-284. PubMed ID: 29660509
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and Safety Evaluation of Mometasone Furoate in Treating Ocular Inflammation.
Lage NA; de Paiva MRB; Vasconcelos-Santos DV; Machado RR; Fialho SL; Silva-Cunha A
Pharmaceutics; 2023 Jan; 15(1):. PubMed ID: 36678822
[TBL] [Abstract][Full Text] [Related]
6. Intravitreal thalidomide ameliorates inflammation in a model of experimental uveitis induced by BCG.
Castro BFM; Vieira LC; Vasconcelos-Santos DV; Cenachi SPF; Cotta OAL; Guerra MCA; Paiva MRB; Silva LM; Silva-Cunha A; Fialho SL
Int Immunopharmacol; 2020 Apr; 81():106129. PubMed ID: 32018067
[TBL] [Abstract][Full Text] [Related]
7. Toxicity and in vivo release profile of sirolimus from implants into the vitreous of rabbits' eyes.
De Paiva MRB; Lage NA; Guerra MCA; Mol MPG; Ribeiro MCS; Fulgêncio GO; Gomes DA; Da Costa César I; Fialho SL; Silva-Cunha A
Doc Ophthalmol; 2019 Feb; 138(1):3-19. PubMed ID: 30456454
[TBL] [Abstract][Full Text] [Related]
8. Bevacizumab-Conjugated Quantum Dots:
Santana CP; Mansur AAP; Mansur HS; Silva-Cunha AD
J Ocul Pharmacol Ther; 2020; 36(6):467-483. PubMed ID: 32522096
[No Abstract] [Full Text] [Related]
9. Inhibition of RPE cell sterile inflammatory responses and endotoxin-induced uveitis by a cell-impermeable HSP90 inhibitor.
Qin S; Ni M; Wang X; Maurier-Mahé F; Shurland DL; Rodrigues GA
Exp Eye Res; 2011 Dec; 93(6):889-97. PubMed ID: 22019372
[TBL] [Abstract][Full Text] [Related]
10. Fluocinolone inhibits VEGF expression via glucocorticoid receptor in human retinal pigment epithelial (ARPE-19) cells and TNF-alpha-induced angiogenesis in chick chorioallantoic membrane (CAM).
Ayalasomayajula SP; Ashton P; Kompella UB
J Ocul Pharmacol Ther; 2009 Apr; 25(2):97-103. PubMed ID: 19284324
[TBL] [Abstract][Full Text] [Related]
11. Intraocular DHODH-inhibitor PP-001 suppresses relapsing experimental uveitis and cytokine production of human lymphocytes, but not of RPE cells.
Diedrichs-Möhring M; Niesik S; Priglinger CS; Thurau SR; Obermayr F; Sperl S; Wildner G
J Neuroinflammation; 2018 Feb; 15(1):54. PubMed ID: 29467002
[TBL] [Abstract][Full Text] [Related]
12. Effects of intravitreal injection of tacrolimus (FK506) in experimental uveitis.
Ishikawa T; Hokama H; Katagiri Y; Goto H; Usui M
Curr Eye Res; 2005 Feb; 30(2):93-101. PubMed ID: 15814467
[TBL] [Abstract][Full Text] [Related]
13. The Protective Effects of VVN001 on LPS-Induced Inflammatory Responses in Human RPE Cells and in a Mouse Model of EIU.
Qiu R; Yang M; Wang W; Liu J; Yang L; Lei B
Inflammation; 2021 Apr; 44(2):780-794. PubMed ID: 33200357
[TBL] [Abstract][Full Text] [Related]
14. Scleral plug of biodegradable polymers containing tacrolimus (FK506) for experimental uveitis.
Sakurai E; Nozaki M; Okabe K; Kunou N; Kimura H; Ogura Y
Invest Ophthalmol Vis Sci; 2003 Nov; 44(11):4845-52. PubMed ID: 14578407
[TBL] [Abstract][Full Text] [Related]
15. Anatomical and visual outcomes of ranibizumab injections in retinal pigment epithelium tears.
Erol MK; Ozdemir O; Coban DT; Ceran BB; Sari ES
Arq Bras Oftalmol; 2015; 78(3):168-72. PubMed ID: 26222106
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of pharmacological activities and assessment of intraocular penetration of an ayurvedic polyherbal eye drop (Itone™) in experimental models.
Velpandian T; Gupta P; Ravi AK; Sharma HP; Biswas NR
BMC Complement Altern Med; 2013 Jan; 13():1. PubMed ID: 23280361
[TBL] [Abstract][Full Text] [Related]
17. Intravitreal connective tissue growth factor neutralizing antibody or bevacizumab alone or in combination for prevention of proliferative vitreoretinopathy in an experimental model.
Daftarian N; Baigy O; Suri F; Kanavi MR; Balagholi S; Afsar Aski S; Moghaddasi A; Nourinia R; Abtahi SH; Ahmadieh H
Exp Eye Res; 2021 Jul; 208():108622. PubMed ID: 34022176
[TBL] [Abstract][Full Text] [Related]
18. Protective effects of the galectin-1 protein on in vivo and in vitro models of ocular inflammation.
Zanon Cde F; Sonehara NM; Girol AP; Gil CD; Oliani SM
Mol Vis; 2015; 21():1036-50. PubMed ID: 26392742
[TBL] [Abstract][Full Text] [Related]
19. Intravitreal injection of peptides PnPa11 and PnPa13, derivatives of
Dourado LFN; da Silva FR; Toledo CR; da Silva CN; Santana CP; da Costa BL; de Lima ME; Cunha ADS
J Venom Anim Toxins Incl Trop Dis; 2020; 26():e20200031. PubMed ID: 33014024
[TBL] [Abstract][Full Text] [Related]
20. The anti-inflammatory effect of minocycline on endotoxin-induced uveitis and retinal inflammation in rats.
Yuan Z; Chen X; Yang W; Lou B; Ye N; Liu Y
Mol Vis; 2019; 25():359-372. PubMed ID: 31354229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
